Regulation of insulin receptor tyrosine kinase by metabolic intermediates.
Vicario
P P
PP
Merck Institute for Therapeutic Research, Department of Biochemical Endocrinology, Rahway, NJ 07065.
Bennun
A
A
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D004789:Enzyme Activation / Q000187:drug effects; D005635:Fructosediphosphates / Q000494:pharmacology; D019298:Glucose-6-Phosphate; D005958:Glucosephosphates / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008345:Manganese / Q000494:pharmacology; D010728:Phosphoenolpyruvate / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D051381:Rats; D011972:Receptor, Insulin
D002951:Citrates; D005635:Fructosediphosphates; D005958:Glucosephosphates; D019343:Citric Acid; D008345:Manganese; D019298:Glucose-6-Phosphate; D010728:Phosphoenolpyruvate; D011505:Protein-Tyrosine Kinases; D011972:Receptor, Insulin; D000262:Adenylyl Cyclases; C029063:fructose-1,6-diphosphate